Audit of the Drug Enforcement Administration's Prescription Drug Take Back Activities
- NARA ID
- audit-drug-enforcement-administrations-prescription-drug-take-back-activities
- Source
- oig-doj
- Collection
- DOJ OIG — Drug Enforcement Administration
- Agency
- U.S. DOJ Office of the Inspector General
- Classification
- Audit
- Released
- 2020-09-29
- Slug
- doj-oig-audit-drug-enforcement-administrations-prescription-drug-take-back-activities
- Indexed
- 2026-04-27 05:03:38
More from DOJ OIG — Drug Enforcement Administration
- Summary of OIG Investigative Findings Regarding the Detention by the Drug Enforcement Administration of Daniel Chong
- Management Advisory Memorandum – Notification of Concerns Identified in the Drug Enforcement Administration’s Use of Polygraph Examinations in Pre-employment Vetting
- Drug Enforcement Administration Annual Financial Statement - Fiscal Year 2009
- Review of the Drug Enforcement Administration’s Accounting of Drug Control Funding Fiscal Year 2025
- Report of Investigation Regarding the DEA's Relationship with K. Wayne McLeod
- Audit of the Drug Enforcement Administration's Asset Forfeiture Program Task Orders Awarded to Maximus, Inc., for Financial Investigative Services
Browse all 60 documents in DOJ OIG — Drug Enforcement Administration →
About the DOJ OIG — Drug Enforcement Administration collection
U.S. DOJ Office of the Inspector General reports (audits, investigations, evaluations, and reviews) concerning Drug Enforcement Administration.